| epidermis development | GO:0008544 | 187 | 0.899 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.779 | |
| skin development | GO:0043588 | 220 | 0.511 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.364 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.355 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.353 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.352 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.341 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.339 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.338 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.330 | |
| embryonic placenta development | GO:0001892 | 98 | 0.323 | |
| protein processing | GO:0016485 | 163 | 0.254 | |
| camera type eye development | GO:0043010 | 266 | 0.249 | |
| epithelial cell development | GO:0002064 | 159 | 0.248 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.242 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.239 | |
| hair follicle development | GO:0001942 | 85 | 0.232 | |
| kidney development | GO:0001822 | 213 | 0.223 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.221 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.221 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.220 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.212 | |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.207 | |
| molting cycle | GO:0042303 | 90 | 0.207 | |
| muscle tissue development | GO:0060537 | 308 | 0.204 | |
| intermediate filament based process | GO:0045103 | 27 | 0.196 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.193 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.189 | |
| skeletal system development | GO:0001501 | 356 | 0.181 | |
| cardiac septum development | GO:0003279 | 59 | 0.179 | |
| skin morphogenesis | GO:0043589 | 38 | 0.172 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.166 | |
| wound healing | GO:0042060 | 157 | 0.166 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.160 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.158 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.157 | |
| stem cell development | GO:0048864 | 219 | 0.154 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.154 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.151 | |
| placenta development | GO:0001890 | 140 | 0.150 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.149 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.148 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.148 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.144 | |
| cell adhesion | GO:0007155 | 329 | 0.143 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.143 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.143 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.143 | |
| male gamete generation | GO:0048232 | 285 | 0.141 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.139 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.138 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.137 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.136 | |
| appendage development | GO:0048736 | 166 | 0.134 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.134 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.131 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.131 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.131 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.130 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.130 | |
| protein maturation | GO:0051604 | 176 | 0.129 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.128 | |
| stem cell differentiation | GO:0048863 | 268 | 0.128 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.126 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.125 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.124 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.124 | |
| maintenance of cell number | GO:0098727 | 3 | 0.122 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.122 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.121 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.120 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.120 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.117 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.116 | |
| nephron epithelium development | GO:0072009 | 92 | 0.116 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.116 | |
| ear development | GO:0043583 | 200 | 0.115 | |
| intermediate filament organization | GO:0045109 | 15 | 0.114 | |
| cerebellum formation | GO:0021588 | 1 | 0.114 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.114 | |
| urogenital system development | GO:0001655 | 261 | 0.114 | |
| tissue regeneration | GO:0042246 | 22 | 0.113 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.111 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.110 | |
| mitral valve development | GO:0003174 | 4 | 0.109 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.108 | |
| mapk cascade | GO:0000165 | 281 | 0.108 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.107 | |
| renal system development | GO:0072001 | 225 | 0.106 | |
| intermediate filament bundle assembly | GO:0045110 | 3 | 0.106 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.105 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.104 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.104 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.103 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.102 | |
| regulation of protein processing | GO:0070613 | 96 | 0.102 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.102 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.102 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.102 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.101 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.101 | |
| hair cycle | GO:0042633 | 90 | 0.101 | |
| extracellular structure organization | GO:0043062 | 148 | 0.101 | |
| primary neural tube formation | GO:0014020 | 95 | 0.100 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.100 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.099 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.099 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.097 | |
| nephron development | GO:0072006 | 109 | 0.097 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.096 | |
| gas homeostasis | GO:0033483 | 3 | 0.096 | |
| neural tube development | GO:0021915 | 160 | 0.096 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.095 | |
| gland development | GO:0048732 | 330 | 0.094 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.093 | |
| regulation of anagen | GO:0051884 | 1 | 0.093 | |
| spemann organizer formation | GO:0060061 | 2 | 0.093 | |
| spermatogenesis | GO:0007283 | 284 | 0.092 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.092 | |
| female sex differentiation | GO:0046660 | 84 | 0.091 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.090 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.090 | |
| mesoderm development | GO:0007498 | 100 | 0.090 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.089 | |
| limb development | GO:0060173 | 166 | 0.089 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.088 | |
| nephron tubule development | GO:0072080 | 84 | 0.088 | |
| somitogenesis | GO:0001756 | 69 | 0.087 | |
| heart morphogenesis | GO:0003007 | 178 | 0.087 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.086 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.086 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.085 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.085 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.082 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.081 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.081 | |
| midgut development | GO:0007494 | 4 | 0.080 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.079 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.078 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.078 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.078 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.077 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.077 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.077 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.076 | |
| oxidation reduction process | GO:0055114 | 342 | 0.076 | |
| epithelial tube formation | GO:0072175 | 130 | 0.076 | |
| cell cell junction organization | GO:0045216 | 72 | 0.075 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.075 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.075 | |
| muscle system process | GO:0003012 | 141 | 0.074 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.073 | |
| response to inorganic substance | GO:0010035 | 96 | 0.073 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.073 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.073 | |
| cardiac chamber development | GO:0003205 | 108 | 0.072 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.072 | |
| ureteric bud development | GO:0001657 | 94 | 0.071 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.071 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.071 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.071 | |
| endomembrane system organization | GO:0010256 | 147 | 0.070 | |
| muscle fiber development | GO:0048747 | 76 | 0.070 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.070 | |
| mesonephros development | GO:0001823 | 97 | 0.070 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.070 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.070 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.070 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.069 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.069 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.069 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.069 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.068 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.068 | |
| respiratory system development | GO:0060541 | 190 | 0.067 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.067 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.066 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.066 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.066 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.066 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.065 | |
| blood circulation | GO:0008015 | 195 | 0.065 | |
| renal vesicle induction | GO:0072034 | 3 | 0.065 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.065 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.064 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.064 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.064 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.064 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.064 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.064 | |
| amine metabolic process | GO:0009308 | 45 | 0.064 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.063 | |
| lung induction | GO:0060492 | 3 | 0.063 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.063 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.063 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.063 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.062 | |
| cell junction maintenance | GO:0034331 | 4 | 0.062 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.062 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.061 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.061 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.061 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.061 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.061 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.061 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.061 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.060 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.059 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.059 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.059 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.059 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.058 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.058 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.058 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.058 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.057 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.057 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.057 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.056 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.056 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.056 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.056 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.056 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.056 | |
| neural crest cell development | GO:0014032 | 48 | 0.056 | |
| positive regulation of hair follicle development | GO:0051798 | 6 | 0.056 | |
| tube closure | GO:0060606 | 91 | 0.056 | |
| striated muscle cell development | GO:0055002 | 125 | 0.056 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.055 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.055 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.055 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.055 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.055 | |
| axon guidance | GO:0007411 | 141 | 0.055 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.055 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.055 | |
| male sex differentiation | GO:0046661 | 109 | 0.054 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.054 | |
| actin filament organization | GO:0007015 | 113 | 0.054 | |
| somite development | GO:0061053 | 81 | 0.053 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.053 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.053 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.053 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.053 | |
| muscle cell development | GO:0055001 | 133 | 0.053 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.053 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.053 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.053 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.053 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.053 | |
| cell division | GO:0051301 | 120 | 0.052 | |
| digestive tract development | GO:0048565 | 190 | 0.052 | |
| gastrulation | GO:0007369 | 116 | 0.052 | |
| regionalization | GO:0003002 | 337 | 0.052 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.052 | |
| fat cell differentiation | GO:0045444 | 160 | 0.051 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.051 | |
| regulation of cell growth | GO:0001558 | 91 | 0.051 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.051 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.051 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.050 | |
| protein catabolic process | GO:0030163 | 221 | 0.050 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.050 | |
| positive regulation of cell division | GO:0051781 | 31 | 0.050 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.050 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.050 | |
| inflammatory response | GO:0006954 | 244 | 0.049 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.049 | |
| kidney epithelium development | GO:0072073 | 121 | 0.049 | |
| developmental maturation | GO:0021700 | 193 | 0.049 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.049 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.049 | |
| regulation of ossification | GO:0030278 | 112 | 0.049 | |
| t cell activation | GO:0042110 | 289 | 0.048 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.048 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.048 | |
| artery development | GO:0060840 | 53 | 0.048 | |
| lung field specification | GO:0060424 | 3 | 0.048 | |
| cerebellar granular layer development | GO:0021681 | 13 | 0.048 | |
| regulation of tube size | GO:0035150 | 57 | 0.048 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.048 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.048 | |
| angiogenesis | GO:0001525 | 201 | 0.048 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.048 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.047 | |
| tube formation | GO:0035148 | 140 | 0.047 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.047 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.047 | |
| negative regulation of growth | GO:0045926 | 99 | 0.047 | |
| tight junction assembly | GO:0070830 | 9 | 0.047 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.047 | |
| endocytosis | GO:0006897 | 168 | 0.047 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.046 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.046 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.046 | |
| neuronal action potential | GO:0019228 | 54 | 0.046 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.046 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.046 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.046 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.045 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.045 | |
| neural tube formation | GO:0001841 | 108 | 0.045 | |
| blastocyst formation | GO:0001825 | 33 | 0.045 | |
| metanephros development | GO:0001656 | 79 | 0.045 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.045 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.045 | |
| regulation of neuron death | GO:1901214 | 134 | 0.045 | |
| cellular response to starvation | GO:0009267 | 57 | 0.045 | |
| limb morphogenesis | GO:0035108 | 149 | 0.044 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.044 | |
| cell maturation | GO:0048469 | 127 | 0.044 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.044 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.044 | |
| renal tubule development | GO:0061326 | 87 | 0.044 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.044 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.044 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.043 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.043 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.043 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.043 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.043 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.043 | |
| b cell activation | GO:0042113 | 161 | 0.043 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.043 | |
| ossification | GO:0001503 | 216 | 0.043 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.043 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.042 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.042 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.042 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.042 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.042 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.042 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.041 | |
| regulation of wound healing | GO:0061041 | 40 | 0.041 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.041 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.041 | |
| water homeostasis | GO:0030104 | 27 | 0.041 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.041 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.041 | |
| gonad development | GO:0008406 | 141 | 0.041 | |
| neuron death | GO:0070997 | 154 | 0.041 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.041 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.041 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.041 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.041 | |
| compound eye development | GO:0048749 | 1 | 0.041 | |
| forebrain development | GO:0030900 | 302 | 0.041 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.041 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.041 | |
| lipoxin a4 biosynthetic process | GO:2001303 | 1 | 0.040 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.040 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.040 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.040 | |
| response to growth factor | GO:0070848 | 198 | 0.040 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.040 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.040 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.040 | |
| hindbrain formation | GO:0021576 | 1 | 0.040 | |
| regulation of system process | GO:0044057 | 200 | 0.040 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.039 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.039 | |
| regulation of t cell apoptotic process | GO:0070232 | 28 | 0.039 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.039 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.039 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.039 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.039 | |
| protein localization to membrane | GO:0072657 | 108 | 0.039 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.039 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.038 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.038 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.038 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.038 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.038 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.038 | |
| nephric duct formation | GO:0072179 | 4 | 0.038 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.038 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.038 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.038 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.037 | |
| steroid metabolic process | GO:0008202 | 119 | 0.037 | |
| renal inner medulla development | GO:0072053 | 3 | 0.037 | |
| telencephalon development | GO:0021537 | 186 | 0.037 | |
| microtubule based process | GO:0007017 | 236 | 0.037 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.037 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.037 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.037 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.037 | |
| female gamete generation | GO:0007292 | 74 | 0.037 | |
| gtp catabolic process | GO:0006184 | 143 | 0.037 | |
| renal outer medulla development | GO:0072054 | 2 | 0.036 | |
| loop of henle development | GO:0072070 | 10 | 0.036 | |
| pallium development | GO:0021543 | 120 | 0.036 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.036 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.036 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.036 | |
| myotube differentiation | GO:0014902 | 105 | 0.036 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.036 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.035 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.035 | |
| metencephalon development | GO:0022037 | 89 | 0.035 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.035 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.035 | |
| nuclear transport | GO:0051169 | 139 | 0.035 | |
| regulation of cell activation | GO:0050865 | 289 | 0.035 | |
| segmentation | GO:0035282 | 93 | 0.035 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.035 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.034 | |
| myotube cell development | GO:0014904 | 60 | 0.034 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.034 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.034 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.034 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.034 | |
| circulatory system process | GO:0003013 | 197 | 0.034 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.034 | |
| cerebellum development | GO:0021549 | 77 | 0.034 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.034 | |
| neuron migration | GO:0001764 | 122 | 0.033 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.033 | |
| digestive system development | GO:0055123 | 200 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.033 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.033 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.033 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.033 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.033 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.033 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.033 | |
| neural tube closure | GO:0001843 | 90 | 0.033 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.033 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.033 | |
| cochlea development | GO:0090102 | 35 | 0.032 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.032 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.032 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.032 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.032 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.032 | |
| mesonephric duct development | GO:0072177 | 5 | 0.032 | |
| ventricular septum development | GO:0003281 | 42 | 0.032 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.032 | |
| cerebellar granular layer morphogenesis | GO:0021683 | 10 | 0.032 | |
| organelle fission | GO:0048285 | 170 | 0.032 | |
| female gonad development | GO:0008585 | 71 | 0.032 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.032 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.032 | |
| mitochondrion organization | GO:0007005 | 134 | 0.031 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.031 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.031 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.031 | |
| multi organism behavior | GO:0051705 | 62 | 0.031 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.031 | |
| stem cell maintenance | GO:0019827 | 130 | 0.031 | |
| cerebellar granular layer formation | GO:0021684 | 9 | 0.031 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.031 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.031 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.031 | |
| regulation of protein localization | GO:0032880 | 231 | 0.031 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.031 | |
| organelle assembly | GO:0070925 | 177 | 0.030 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.030 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.030 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.030 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.030 | |
| lipoxygenase pathway | GO:0019372 | 5 | 0.030 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.030 | |
| heart contraction | GO:0060047 | 93 | 0.030 | |
| mesoderm formation | GO:0001707 | 62 | 0.030 | |
| odontogenesis | GO:0042476 | 78 | 0.030 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.030 | |
| developmental induction | GO:0031128 | 34 | 0.030 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.030 | |
| innate immune response | GO:0045087 | 157 | 0.030 | |
| protein secretion | GO:0009306 | 111 | 0.030 | |
| synapse organization | GO:0050808 | 125 | 0.030 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.030 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.030 | |
| cerebellar granule cell differentiation | GO:0021707 | 9 | 0.029 | |
| response to radiation | GO:0009314 | 165 | 0.029 | |
| negative regulation of t cell apoptotic process | GO:0070233 | 18 | 0.029 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.029 | |
| establishment of planar polarity of embryonic epithelium | GO:0042249 | 16 | 0.029 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.029 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.029 | |
| chromatin organization | GO:0006325 | 206 | 0.029 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.029 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.028 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.028 | |
| cell recognition | GO:0008037 | 83 | 0.028 | |
| cornea development in camera type eye | GO:0061303 | 6 | 0.028 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.028 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.028 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.028 | |
